Pharmacological Modulation of Gut Microbiota in Metabolic Syndrome
Abstract
Gut microbiota has been identified as a regulator of metabolic health, especially the metabolism syndrome (MetS), which is a multifactorial disease, including obesity, insulin resistance, dyslipidemia, and hypertension. Recent preclinical models involving rodents exposed to high-fat diets have demonstrated therapeutic benefits of pharmacological agents (e.g. metformin, berberine, and probiotics, prebiotics, and bile acid modulators, to mention a few) not only on direct molecular targets but also on the gut microbiome. These agents Walter U. [2016] Enhance the abundance of probiotic microbial taxa such as Akkermansia muciniphila and Bifidobacterium, Short chain fatty acid (SCFA) production, and improve gut barrier integrity as well as attenuate systemic inflammation and metabolic endotoxemia. The review is critical in assessing the methods, results, and actions taken by these interventions to improve host-microbiota interactions in the alleviation of MetS characteristics, such as raised insulin sensitivity, glucose, and lipid metabolism. It is also discussing some critical drawbacks of existing preclinical models, including species-level disparities in microbiota and the brevity of observation, which could be problematic to translate to clinical settings. It gives prominence on the implications on microbiota-modulating treatments, integrations of microbiome-modulating adjuncts, and how this can be studied further, such as long-term studies and individual approaches to…
Read the paper
Related studies
- Bile Acid 7α-Dehydroxylating Gut Bacteria Secrete Antibiotics that Inhibit Clostridium difficile: Role of Secondary Bile Acids
- Ketogenic diet alleviates colitis by reduction of colonic group 3 innate lymphoid cells through altering gut microbiome
- Altered gut microbiome composition and function are associated with gut barrier dysfunction in healthy relatives of patients with Crohn's disease
- Diet, obesity, and the gut microbiome as determinants modulating metabolic outcomes in a non-human primate model
- Immune Impairment Associated with Vitamin A Deficiency: Insights from Clinical Studies and Animal Model Research
- Glyphosate-based herbicides influence antioxidants, reproductive hormones and gut microbiome but not reproduction: A long-term experiment in an avian model
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.